(B) Cells were pretreated with or without GLP-1 (10 nM) for 1 h in addition of Ex-9 (10 nM), incubated with H 2 O 2 (1 mM) for 12 h, and then cell viability was assessed with MTT assay, n = 6
Tirzepatide is not a hormone replacement therapy but influences metabolic hormones indirectly through its dual GIP/GLP-1 receptor actions, improving insulin secretion, reducing glucagon, and affecting appetite-regulating pathways
PlexusDx patients report similar weight loss results when paired with lifestyle modifications and provider monitoring
Treatment was prematurely discontinued by 10% of participants in the 5-mg tirzepatide group, 12% in the 10-mg tirzepatide group, 18% in the 15-mg tirzepatide group, and 3% in the placebo group
In this article, well take a closer look at GLP-1 supplement products, what they typically contain, how theyre marketed, and why regulators may be keeping a close eye on them
Cagrilintide combined with semaglutide (CagriSema) represents the next generation of combination therapies